CoChat

Characterization of the mutation responsible for aspartylglucosaminuria in three Finnish patients. Amino acid substitution Cys163—-Ser abolishes the activity of lysosomal glycosylasparaginase and its conversion into subunits

Open access
Fisher, K.J., Aronson, N.N. · 1991 · Journal of Biological Chemistry

The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.

Abstract

The mutation that causes a deficiency of the lysosomal amidase, glycosylasparaginase, has been characterized in fibroblasts from three Finnish patients diagnosed with aspartylglucosaminuria (AGU). The polymerase chain reaction was used to amplify the glycosylasparaginase protein coding sequence from the three AGU patients in order to compare them to the normal sequence from a full-length human placenta cDNA clone HPAsn.6 (Fisher, K.J., Tollersrud, O.K., and Aronson, N.N., Jr. (1990) FEBS Lett. 269, 440-444). Two base changes were found to be common to all three Finnish AGU patients, a G482----A transition that results in an Arg161----Gln substitution and a G488----C transversion that causes Cys163----Ser. Detection of both point mutations from PCR-amplified cDNA or genomic DNA was facilitated by their creation of new endonuclease restriction sites. Expression studies in COS-1 cells revealed only the Cys163----Ser mutation caused a deficiency of glycosylasparaginase activity. This same substitution also prevented the normal posttranslational processing of the precursor glycosylasparaginase polypeptide into its alpha and beta subunits. Cell-free expression of the single-chain glycosylasparaginase precusor did not produce an active enzyme, suggesting that post-translational generation of subunits may be required for catalytic activity.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0021-9258(18)99071-x

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Research works printed but not linked: 3

  1. Jenner, 1967, Biochem. J, 103, 48P
  2. Aula, 1986, J. Ment. Defic. Res, 30, 365
  3. Kincaid, 1988, BioTechniques, 6, 42

Cited by

See all 52

Metadata

Authors
Fisher, K. J., & Aronson, N. N.
Affiliations
Pennsylvania State University (US)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1991-06
Volume
266
Issue
18
Pages
12105-12113
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1502576134
Cited by
52
References
37
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 2 · 2021: 2 · 2020: 3 · 2017: 1 · 2016: 2 · 2014: 3
FWCI
3.73
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01dk033314-12)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK33314)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
Keywords
aspartylglucosaminuria, glycosylasparaginase, point mutations, post-translational processing, enzyme activity loss, Finnish patients, fibroblasts, restriction site mutations
MeSH terms
Acetylglucosamine, Amino Acid Sequence, Aspartylglucosylaminase, Base Sequence, Cysteine, DNA, Fibroblasts, Finland, Humans, Lysosomes, Molecular Sequence Data, Mutation, RNA, Messenger, Serine, Protein Biosynthesis, Blotting, Southern, Blotting, Northern, Restriction Mapping, Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterization of the mutation responsible for aspartylglucosaminuria in three Finnish patients. Amino acid substitution Cys163—-Ser abolishes the activity of lysosomal glycosylasparaginase and its conversion into subunits. https://app.cochat.ai/papers/10.1016/s0021-9258(18)99071-x
The paper
Fisher, K. J., & Aronson, N. N. (1991). Characterization of the mutation responsible for aspartylglucosaminuria in three Finnish patients. Amino acid substitution Cys163—-Ser abolishes the activity of lysosomal glycosylasparaginase and its conversion into subunits. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(18)99071-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.